BAX Baxter International Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BAX

Price (delayed)

$39.955

Market cap

$20.29B

P/E Ratio

7.61

Dividend/share

$1.16

EPS

$5.25

Enterprise value

$31.33B

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating ...

Highlights
The company's equity rose by 44% YoY and by 3.7% QoQ
Baxter International's debt has decreased by 17% YoY and by 16% from the previous quarter
The quick ratio is down by 33% since the previous quarter
The gross margin is down by 3.7% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.baxter.com
Peers: CAH BSX SYK BDX

Key stats

What are the main financial stats of BAX
Market
Shares outstanding
507.83M
Market cap
$20.29B
Enterprise value
$31.33B
Valuations
Price to earnings (P/E)
7.61
Price to book (P/B)
2.41
Price to sales (P/S)
1.36
EV/EBIT
10.23
EV/EBITDA
7.24
EV/Sales
2.12
Earnings
Revenue
$14.81B
EBIT
$3.06B
EBITDA
$4.33B
Free cash flow
$1.03B
Per share
EPS
$5.25
Free cash flow per share
$2.04
Book value per share
$16.56
Revenue per share
$29.27
TBVPS
$30.99
Balance sheet
Total assets
$28.28B
Total liabilities
$19.81B
Debt
$14.24B
Equity
$8.4B
Working capital
$3.1B
Liquidity
Debt to equity
1.69
Current ratio
1.48
Quick ratio
0.9
Net debt/EBITDA
2.55
Margins
EBITDA margin
29.2%
Gross margin
33.6%
Net margin
17.9%
Operating margin
2.6%
Efficiency
Return on assets
9.2%
Return on equity
38%
Return on invested capital
13.2%
Return on capital employed
14.1%
Return on sales
20.7%
Dividend
Dividend yield
2.9%
DPS
$1.16
Payout ratio
22.1%

BAX stock price

How has the Baxter International stock price performed over time
Intraday
0.77%
1 week
-0.93%
1 month
-4.76%
1 year
-8.4%
YTD
3.35%
QTD
-6.52%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$14.81B
Gross profit
$4.98B
Operating income
$390M
Net income
$2.66B
Gross margin
33.6%
Net margin
17.9%
The operating margin has soared by 117% YoY but it has decreased by 7% from the previous quarter
Baxter International's operating income has soared by 117% YoY but it has decreased by 4.4% from the previous quarter
The gross margin is down by 3.7% year-on-year
Baxter International's net margin has increased by 2.3% from the previous quarter

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
BAX P/E details
P/E
7.61
P/B
2.41
P/S
1.36
EV/EBIT
10.23
EV/EBITDA
7.24
EV/Sales
2.12
The EPS has grown by 2.3% from the previous quarter
BAX's P/B is 47% below its 5-year quarterly average of 4.5 and 23% below its last 4 quarters average of 3.1
The company's equity rose by 44% YoY and by 3.7% QoQ
BAX's P/S is 53% below its 5-year quarterly average of 2.9 and 3.6% below its last 4 quarters average of 1.4
The revenue is up by 2.1% year-on-year

Efficiency

How efficient is Baxter International business performance
The ROIC has increased by 12% from the previous quarter
The company's return on equity fell by 7% QoQ
The ROS has grown by 6% from the previous quarter
The ROA has grown by 2.2% from the previous quarter

Dividends

What is BAX's dividend history
Dividend details
DPS
$1.16
Dividend yield
2.9%
Payout ratio
22.1%
Recent dividends

Financial health

How did Baxter International financials performed over time
The total assets is 43% more than the total liabilities
The quick ratio is down by 33% since the previous quarter
The current ratio fell by 24% QoQ and by 12% YoY
Baxter International's debt is 69% more than its equity
The company's equity rose by 44% YoY and by 3.7% QoQ
The debt to equity has declined by 42% year-on-year and by 19% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.